Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.44 |
| ▸ | CES1 | P23141 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | FABP3 | P05413 | 6/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycolic Acid SCHEMBL7650210 | 1.00 | CES2 (0.44) | CES2CES1CA1FABP3GPR84 | |
| Glycolic Acid SCHEMBL630796 | 0.91 | CA1 (0.46) | CES2CES1CA1FABP3CA2 | |
| Propionic Acid SCHEMBL6432651 | 0.89 | CES2 (0.46) | CES2CES1CA1FABP3GPR84 | |
| Propionic Acid SCHEMBL9858986 | 0.89 | CES2 (0.46) | CES2CES1CA1FABP3GPR84 | |
| Glycolic Acid SCHEMBL1719239 | 0.87 | CA1 (0.43) | CES2CES1CA1FABP3CA2 | |
| Succinic Acid SCHEMBL10749603 | 0.87 | CA1 (0.54) | CES2CES1CA1FABP3GPR84 | |
| Acetic Acid SCHEMBL123724 | 0.86 | CES1 (0.48) | CES2CES1CA1FABP3GPR84 | |
| Acetic Acid SCHEMBL630646 | 0.86 | CES1 (0.48) | CES2CES1CA1FABP3GPR84 | |
| Acetic Acid SCHEMBL3826722 | 0.86 | CES1 (0.48) | CES2CES1CA1FABP3GPR84 | |
| Oxalic Acid SCHEMBL10749415 | 0.86 | CES2 (0.48) | CES2CES1FABP3GPR84CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3875541-B1 | COMPOSITION AND METHOD FOR PRODUCING SILICONE MASSES AND USE THEREOF | POLYU GMBH (DE) | 2024-08-14 | — | — | EP | claimed |
| US-20230272147-A1 | SELECTIVE POLYURETHANE PREPOLYMER SYNTHESIS | POLYU GMBH (DE) | 2023-08-31 | — | — | US | claimed |
| EP-4196513-A1 | SELECTIVE POLYURETHANE PREPOLYMER SYNTHESIS | PolyU GmbH (DE) | 2023-06-21 | — | — | EP | claimed |
| US-20230097205-A1 | COMPOSITION AND METHOD FOR PRODUCING SILICONE COMPOUNDS, AND USE THEREOF | POLYU GMBH (DE) | 2023-03-30 | — | — | US | claimed |
| US-20220372285-A1 | SELECTIVE POLYURETHANE PREPOLYMER SYNTHESIS | POLYU GMBH (DE) | 2022-11-24 | — | — | US | claimed |
| US-20220235171-A1 | COMPOSITION AND PROCESS FOR PREPARING MOISTURE-CROSSLINKING POLYMERS AND USE THEREOF | POLYU GMBH (DE) | 2022-07-28 | — | — | US | claimed |
| US-20220235169-A1 | METAL-SILOXANE-SILANOL(ATE) COMPOUND AS GEL CATALYST | POLYU GMBH (DE) | 2022-07-28 | — | — | US | claimed |
| CN-114729092-A | Selective polyurethane prepolymer synthesis | 波利有限公司 | 2022-07-08 | — | — | CN | claimed |
| EP-3976691-A1 | ISOCYANATE-FREE CHAIN EXTENSION AND CROSSLINKING BY MEANS OF FUNCTIONAL SILANES | PolyU GmbH (DE) | 2022-04-06 | — | — | EP | claimed |
| US-12540211-B2 | Composition and process for producing silylated polymers and use thereof | POLYU GMBH (DE) | 2026-02-03 | — | — | US | disclosed |
| US-12378349-B2 | Selective polyurethane prepolymer synthesis | POLYU GMBH (DE) | 2025-08-05 | — | — | US | disclosed |
| EP-3875541-B1 | COMPOSITION AND METHOD FOR PRODUCING SILICONE MASSES AND USE THEREOF | POLYU GMBH (DE) | 2024-08-14 | — | — | EP | disclosed |
| CN-113631606-B | Composition and method for preparing silanized polymers and use thereof | 波利有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-114729092-B | Selective polyurethane prepolymer synthesis | 波利有限公司 | 2024-04-26 | — | — | CN | disclosed |
| US-20220259365-A1 | COMPOSITION AND PROCESS FOR PRODUCING SILYLATED POLYMERS AND USE THEREOF | POLYU GMBH (DE) | 2022-08-18 | — | — | US | disclosed |
| US-20220235171-A1 | COMPOSITION AND PROCESS FOR PREPARING MOISTURE-CROSSLINKING POLYMERS AND USE THEREOF | POLYU GMBH (DE) | 2022-07-28 | — | — | US | disclosed |
| US-20220235169-A1 | METAL-SILOXANE-SILANOL(ATE) COMPOUND AS GEL CATALYST | POLYU GMBH (DE) | 2022-07-28 | — | — | US | disclosed |
| EP-4013802-A1 | SELECTIVE POLYURETHANE PREPOLYMER SYNTHESIS | PolyU GmbH (DE) | 2022-06-22 | — | — | EP | disclosed |
| WO-2022096485-A1 | ISOCYANATE-TERMINATED POLYURETHANE PREPOLYMER, AQUEOUS FUNCTIONALIZED POLYURETHANE DISPERSION, AND THEIR MANUFACTURING METHODS AND USES | POLYU GMBH (DE) | 2022-05-12 | — | — | WO | disclosed |
| EP-3976691-A1 | ISOCYANATE-FREE CHAIN EXTENSION AND CROSSLINKING BY MEANS OF FUNCTIONAL SILANES | PolyU GmbH (DE) | 2022-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540211-B2 | Composition and process for producing silylated polymers and use thereof | EPCAM, ITGB1, TMSB10 | CES2 4196/4885CES1 4649/4885CA1 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.